These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 1912524

  • 1. Tumor and host molecules important in the organ preference of metastasis.
    Nicolson GL.
    Semin Cancer Biol; 1991 Jun; 2(3):143-54. PubMed ID: 1912524
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes.
    Nicolson GL.
    Curr Opin Oncol; 1991 Feb; 3(1):75-92. PubMed ID: 2043698
    [Abstract] [Full Text] [Related]

  • 3. Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors.
    Nakajima M, Chop AM.
    Semin Cancer Biol; 1991 Apr; 2(2):115-27. PubMed ID: 1655116
    [Abstract] [Full Text] [Related]

  • 4. Adhesion molecules in tumor metastasis.
    Zetter BR.
    Semin Cancer Biol; 1993 Aug; 4(4):219-29. PubMed ID: 8400144
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis.
    Yeatman TJ, Nicolson GL.
    Semin Surg Oncol; 1993 Aug; 9(3):256-63. PubMed ID: 8516614
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of integrins and other cell adhesion molecules in tumor progression and metastasis.
    Albelda SM.
    Lab Invest; 1993 Jan; 68(1):4-17. PubMed ID: 8423675
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of tumor cells with the extracellular matrix.
    Varani J.
    Revis Biol Celular; 1987 Jan; 12():1-113. PubMed ID: 2447614
    [Abstract] [Full Text] [Related]

  • 11. The biochemistry of cancer dissemination.
    Price JT, Bonovich MT, Kohn EC.
    Crit Rev Biochem Mol Biol; 1997 Jan; 32(3):175-253. PubMed ID: 9239493
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
    Persky B, Ostrowski LE, Pagast P, Ahsan A, Schultz RM.
    Cancer Res; 1986 Aug; 46(8):4129-34. PubMed ID: 3524801
    [Abstract] [Full Text] [Related]

  • 13. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis.
    Nicolson GL.
    Exp Cell Res; 1993 Feb; 204(2):171-80. PubMed ID: 8382620
    [Abstract] [Full Text] [Related]

  • 14. Metastatic cell attachment to and invasion of vascular endothelium and its underlying basal lamina using endothelial cell monolayers.
    Nicolson GL, Irimura T, Nakajima M, Estrada J.
    Symp Fundam Cancer Res; 1983 Feb; 36():145-67. PubMed ID: 6382504
    [Abstract] [Full Text] [Related]

  • 15. [Why do tumors metastasize and why to the lung or liver?].
    Burger MM.
    Schweiz Med Wochenschr; 1997 Feb 01; 127(5):142-7. PubMed ID: 9064757
    [Abstract] [Full Text] [Related]

  • 16. Organ preference of metastasis. The role of organ-specifically modulated endothelial cells.
    Pauli BU, Lee CL.
    Lab Invest; 1988 Apr 01; 58(4):379-87. PubMed ID: 3357332
    [Abstract] [Full Text] [Related]

  • 17. [Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors].
    Roeb E, Matern S.
    Z Gastroenterol; 2001 Sep 01; 39(9):807-13. PubMed ID: 11558074
    [Abstract] [Full Text] [Related]

  • 18. Metastatic phenotype: growth factor dependence and integrin expression.
    Perrotti D, Cimino L, Falcioni R, Tibursi G, Gentileschi MP, Sacchi A.
    Anticancer Res; 1990 Sep 01; 10(6):1587-97. PubMed ID: 2285230
    [Abstract] [Full Text] [Related]

  • 19. Involvement of heparanase in tumor metastasis and angiogenesis.
    Vlodavsky I, Michaeli RI, Bar-Ner M, Fridman R, Horowitz AT, Fuks Z, Biran S.
    Isr J Med Sci; 1988 Sep 01; 24(9-10):464-70. PubMed ID: 2462549
    [Abstract] [Full Text] [Related]

  • 20. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S.
    Cancer Res; 1996 Dec 01; 56(23):5309-18. PubMed ID: 8968075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.